Vicus Capital’s Eli Lilly LLY Stock Holding History
Bought
Maintained
Sold
Other funds holding LLY
Vicus Capital's LLY Position: Q2 2026 in Review
Vicus Capital increased its Eli Lilly (LLY) stake by 13% in Q2 2026, buying an estimated $69.5K and bringing the position to 584 shares worth $700K. The position accounts for 0.05% of the portfolio, ranked #163.
Vicus Capital first reported a position in LLY in Q1 2022 and has held it in 17 quarters since. The position peaked at $747K in Q2 2024. 4,633 funds tracked by Wall St. Rank hold LLY as of Q2 2026.
- Vicus Capital held 584 shares of Eli Lilly worth $700K as of Q2 2026.
- Vicus Capital bought 68 Eli Lilly shares in Q2 2026, an estimated $69.5K.
- Eli Lilly made up 0.05% of Vicus Capital's portfolio in Q2 2026, its #163 holding.
- Vicus Capital first reported a position in Eli Lilly in Q1 2022 and has held it in 17 quarters since.
- Vicus Capital's Eli Lilly position peaked at $747K in Q2 2024.
- 4,633 funds tracked by Wall St. Rank held Eli Lilly as of Q2 2026.
Based on Vicus Capital's 13F filing for Q2 2026, filed 5 Aug 2026.